Clinical effect of intravenous carnitine supplementation and the change of blood carnitine levels in hemodialysis patients:an observational study

Clinical effect of intravenous carnitine supplementation and the change of blood carnitine levels in hemodialysis patients:an observational study - Effect of intravenous carnitine supplementation in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010962

Enrollment

Registered

2013-06-14

Start date

2013-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients who receive intravenous carnitine supplementation.

Exclusion criteria

Exclusion criteria: Patients who reject to enter this study

Design outcomes

Primary

Measure	Time frame
The change of blood carnitine levels before and after intravenous carnitine injection.	—

Secondary

Measure	Time frame
Improvement of renal anemia, decrease of cardiovascular events, cramps, and disdialysis syndrome.	—

Countries

Japan

Contacts

Public ContactNoriyuki Hattori

Chiba University, Graduate School of Medicine Department of Emergency and Critical Care Medicine

hat@shogo.com

Outcome results